Sign in

Colorectal cancer: trials that stopped early

Trials on Colorectal cancer that stopped early, each with the reason the sponsor wrote in the registry, quoted word for word. Next to them: finished trials whose registry record links a result paper.

Stopped early

254 stopped trials give a reason in the registry, latest registry update first. 4 more give no reason and are not listed.

  1. Terminated

    Radioembolization in Elderly/ Fragile Patients With mCRC

    Reason given in the registry

    “The medical deviced studied was taken off market”

    Quoted unchanged from ClinicalTrials.gov; record updated 14 May 2026.

    Ended
    Sept 2025
    Phase
    Phase 2
    Run by
    UMC Utrecht
    Registry record
    NCT05092880
  2. Terminated

    Testing Obeticholic Acid for Familial Adenomatous Polyposis

    Reason given in the registry

    “Protocol has been completed prematurely due to poor accrual and study feasibility.”

    Quoted unchanged from ClinicalTrials.gov; record updated 14 May 2026.

    Ended
    Apr 2026
    Phase
    Phase 2
    Run by
    National Cancer Institute (NCI)
    Registry record
    NCT05223036
  3. Suspended

    Biospecimen Collection in Identifying Genetic Changes in Patients With Breast, Prostate, Colorectal, Liver, or Kidney Cancer or Multiple Myeloma Undergoing Surgery

    Reason given in the registry

    “Due to slow accrual on this trial, we will allow sites time to work on close-out procedures and filling out necessary paperwork before taking the steps to forma”

    Quoted unchanged from ClinicalTrials.gov; record updated 13 May 2026.

    Run by
    National Cancer Institute (NCI)
    Registry record
    NCT04955808
  4. Terminated

    A Phase I/II Study With BM7PE Immunotoxin in Colorectal Cancer Patients

    Reason given in the registry

    “After interim-analysis: No signals of clinical or immunological efficacy detected, and decision was made not to continue the trial.”

    Quoted unchanged from ClinicalTrials.gov; record updated 13 May 2026.

    Ended
    May 2025
    Phase
    Phase 1/2
    Run by
    Oslo University Hospital
    Registry record
    NCT04550897
  5. Terminated

    Defunctioning Left-sided Colostomy in Low Anterior Resection for Rectal Cancer

    Reason given in the registry

    “Logistical difficulties at study sites. 16/20 patients included.”

    Quoted unchanged from ClinicalTrials.gov; record updated 8 May 2026.

    Ended
    Jul 2025
    Run by
    Umeå University
    Registry record
    NCT06149741
  6. Suspended

    A Study of VS-6766 and Cetuximab in Patients With Advanced Colorectal Cancer

    Reason given in the registry

    “enrollment goal met pending determination of evaluable subjects”

    Quoted unchanged from ClinicalTrials.gov; record updated 8 May 2026.

    Phase
    Phase 1/2
    Run by
    University of Chicago
    Registry record
    NCT05200442
  7. Suspended

    Autologous CAR-T Cells (WD-01) for Metastatic Colorectal Cancer

    Reason given in the registry

    “Because the implementation of the new regulation policy by the Chinese authority”

    Quoted unchanged from ClinicalTrials.gov; record updated 7 May 2026.

    Phase
    Early phase 1
    Run by
    Wondercel Biotech (ShenZhen)
    Registry record
    NCT06675513
  8. Suspended

    Universal CAR-T Cells (REVO-UWD-01) for Metastatic Colorectal Cancer

    Reason given in the registry

    “Because the implementation of the new regulation policy by the Chinese authority”

    Quoted unchanged from ClinicalTrials.gov; record updated 7 May 2026.

    Phase
    Early phase 1
    Run by
    Wondercel Biotech (ShenZhen)
    Registry record
    NCT06653010
  9. Terminated

    Impact of Preoperative Oral Branched-chain Amino Acids on Reducing Postoperative Insulin Resistance.

    Reason given in the registry

    “The mid-term analysis of the study showed no significant difference between the two groups.”

    Quoted unchanged from ClinicalTrials.gov; record updated 7 May 2026.

    Ended
    Dec 2024
    Run by
    Sun Peng
    Registry record
    NCT05494658
  10. Terminated

    A Study of PF-08046052/SGN-EGFRd2 in Advanced Solid Tumors

    Reason given in the registry

    “The trial was terminated for strategic reasons. The decision was not based on any safety concerns”

    Quoted unchanged from ClinicalTrials.gov; record updated 5 May 2026.

    Ended
    Apr 2026
    Phase
    Phase 1
    Run by
    Seagen, a wholly owned subsidiary of Pfizer
    Registry record
    NCT05983133
  11. Suspended

    Peritoneal Carcinomatosis Leveraging ctDNA Guided Treatment in GI Cancer Study (PERICLES Study)

    Reason given in the registry

    “Pending Protocol amendment”

    Quoted unchanged from ClinicalTrials.gov; record updated 4 May 2026.

    Run by
    Rutgers, The State University of New Jersey
    Registry record
    NCT04929015
  12. Suspended

    Watch and Wait Management on Rectal Cancer Patients Using New Swift Local Therapy

    Reason given in the registry

    “Issues with applicator”

    Quoted unchanged from ClinicalTrials.gov; record updated 24 Apr 2026.

    Run by
    Sir Mortimer B. Davis - Jewish General Hospital
    Registry record
    NCT04336202
  13. Terminated

    "Impact of Pelvic Floor Prehabilitation Using Biofeedback on the Severity of the Low Anterior Resection Syndrome in Patients Undergoing a Total Mesorectal Excision for Rectal Cancer"

    Reason given in the registry

    “lack of inclusion”

    Quoted unchanged from ClinicalTrials.gov; record updated 20 Apr 2026.

    Ended
    Dec 2025
    Run by
    Nantes University Hospital
    Registry record
    NCT03876561
  14. Terminated

    A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of AUR 109 in Patients With Colorectal, Ovarian, and Renal Cancers

    Reason given in the registry

    “Patient recruitment problems.”

    Quoted unchanged from ClinicalTrials.gov; record updated 17 Apr 2026.

    Ended
    Feb 2026
    Phase
    Phase 2
    Run by
    Aurigene Discovery Technologies Limited
    Registry record
    NCT06760702
  15. Terminated

    A Phase 1 Clinical Trial of AUR106 in Patients With Relapsed Advanced Malignancies

    Reason given in the registry

    “Patient recruitment problems”

    Quoted unchanged from ClinicalTrials.gov; record updated 17 Apr 2026.

    Ended
    Feb 2026
    Phase
    Phase 1
    Run by
    Aurigene Discovery Technologies Limited
    Registry record
    NCT05861947
  16. Terminated

    Colorectal Lesion Evaluation and Appropriate Resolution (CLEAR) Study

    Reason given in the registry

    “Study terminated per sponsor decision due to operational reasons. The termination was not a result of any participant safety concerns.”

    Quoted unchanged from ClinicalTrials.gov; record updated 9 Apr 2026.

    Ended
    Mar 2026
    Run by
    Harbinger Health
    Registry record
    NCT07479381
  17. Terminated

    Fluorescent Probe VGT-309 to ID Cancerous Colorectal Lesions During Augmented Colonoscopy

    Reason given in the registry

    “The drug supply expired and the sponsor is unable to provide an updated supply.”

    Quoted unchanged from ClinicalTrials.gov; record updated 8 Apr 2026.

    Ended
    Apr 2025
    Phase
    Early phase 1
    Run by
    Stephan Rogalla
    Registry record
    NCT06034197
  18. Withdrawn

    Monalizumab and MEDI5752 in Patients With MSI and/or dMMR Metastatic Cancer

    Reason given in the registry

    “The study has been halted because the manufacturer can no longer supply the experimental treatment”

    Quoted unchanged from ClinicalTrials.gov; record updated 6 Apr 2026.

    Phase
    Phase 2
    Run by
    Assistance Publique - Hôpitaux de Paris
    Registry record
    NCT06152523
  19. Terminated

    Contents of Circulating Extracellular Vesicles: Biomarkers in Colorectal Cancer Patients

    Reason given in the registry

    “As the laboratory due to carry out the biological analyses withdrew, the project did not go ahead”

    Quoted unchanged from ClinicalTrials.gov; record updated 24 Mar 2026.

    Ended
    Mar 2026
    Run by
    Centre Hospitalier Universitaire Dijon
    Registry record
    NCT04523389
  20. Terminated

    Study With Dehisgel Used in Adult Patients Undergoing Colorectal Anastomosis

    Reason given in the registry

    “safety was ok, but efficacy was considered too low - it was decided not to continue woth this study design”

    Quoted unchanged from ClinicalTrials.gov; record updated 24 Mar 2026.

    Ended
    Dec 2025
    Run by
    Contipro Pharma a.s.
    Registry record
    NCT07490080
  21. Terminated

    A Study to Learn About PF-07921585 Alone or With Other Anti-cancer Medicines in People With Cancer

    Reason given in the registry

    “The trial was terminated for strategic reasons. The decision was not based on any safety and/or efficacy concerns”

    Quoted unchanged from ClinicalTrials.gov; record updated 23 Mar 2026.

    Ended
    Jul 2025
    Phase
    Phase 1
    Run by
    Pfizer
    Registry record
    NCT06580938
  22. Terminated

    Association Between the Composition of the Intestinal Microbiota and Tumor Response in Locally Advanced Rectal Cancer

    Reason given in the registry

    “Lack of eligible patients”

    Quoted unchanged from ClinicalTrials.gov; record updated 18 Mar 2026.

    Ended
    Oct 2024
    Run by
    Centre Oscar Lambret
    Registry record
    NCT06181201
  23. Withdrawn

    Structured TXI-RDI Integration for Endoscopic Resection

    Reason given in the registry

    “Not funded”

    Quoted unchanged from ClinicalTrials.gov; record updated 16 Mar 2026.

    Run by
    Medical College of Wisconsin
    Registry record
    NCT07474844
  24. Withdrawn

    A Trial of Regorafenib Plus Lorigerlimab as Neoadjuvant Therapy for Patients With pMMR/MSS, Resectable, Lung-limited Metastatic Colorectal Cancer

    Reason given in the registry

    “0 participants enrolled”

    Quoted unchanged from ClinicalTrials.gov; record updated 11 Mar 2026.

    Ended
    Jan 2026
    Phase
    Phase 1/2
    Run by
    M.D. Anderson Cancer Center
    Registry record
    NCT07137390
  25. Suspended

    Cryotherapy & Oxaliplatin

    Reason given in the registry

    “Study paused to enrollment”

    Quoted unchanged from ClinicalTrials.gov; record updated 6 Mar 2026.

    Run by
    NYU Langone Health
    Registry record
    NCT06281925
  26. Withdrawn

    Behavioral Nudge in Colorectal Cancer Screening

    Reason given in the registry

    “Study was discontinued due to a lack of feasibility.”

    Quoted unchanged from ClinicalTrials.gov; record updated 25 Feb 2026.

    Ended
    Jul 2026
    Run by
    NYU Langone Health
    Registry record
    NCT06796049
  27. Withdrawn

    A Trial of Regorafenib Plus Lorigerlimab in Patients With Locally Recurrent or Regrowing pMMR/MSS Localized Rectal Cancer

    Reason given in the registry

    “0 participants enrolled”

    Quoted unchanged from ClinicalTrials.gov; record updated 25 Feb 2026.

    Ended
    Jan 2026
    Phase
    Phase 2
    Run by
    M.D. Anderson Cancer Center
    Registry record
    NCT07223567
  28. Terminated

    First-in-Human Study of ATX-559, an Oral Inhibitor of DHX9, in Patients With Advanced or Metastatic Solid Tumors, and Molecularly Defined Cancers

    Reason given in the registry

    “The study was terminated by sponsor based on the adverse event profile.”

    Quoted unchanged from ClinicalTrials.gov; record updated 24 Feb 2026.

    Ended
    Jan 2026
    Phase
    Phase 1
    Run by
    Accent Therapeutics
    Registry record
    NCT06625515
  29. Terminated

    A Study to Learn About How Different Amounts of the Study Medicine PF-07826390 Act in the Body of People With Cancer When Taken Alone or With Other Anti-cancer Medicines.

    Reason given in the registry

    “Study terminated as part of strategic considerations and not based on safety concerns.”

    Quoted unchanged from ClinicalTrials.gov; record updated 23 Feb 2026.

    Ended
    Oct 2025
    Phase
    Phase 1
    Run by
    Pfizer
    Registry record
    NCT06546553
  30. Terminated

    A Study to Investigate Ompenaclid Combined With FOLFIRI Plus Bevacizumab in Advanced/Metastatic Colorectal Cancer

    Reason given in the registry

    “At the time of the primary analysis, results did not meet the primary endpoint”

    Quoted unchanged from ClinicalTrials.gov; record updated 20 Feb 2026.

    Ended
    Mar 2025
    Phase
    Phase 2
    Run by
    Inspirna, Inc.
    Registry record
    NCT05983367

Sources: ClinicalTrials.gov and the EU Clinical Trials Register. Status, reason, dates and result links are registry fields, shown as the registry gives them.